Plasma renin activity and plasma concentrations of aldosterone, cortisol, adrenocorticotropic hormone, and α-melanocyte-stimulating hormone in healthy cats

Journal of Veterinary Internal Medicine

Volumn 18, Issue 5, 2004, Pages 625-631

  Javadi, Shahram ^a   Slingerland, Lars I ^a   Van De Beek, Margreet G ^a   Boer, Peter ^b   Boer, Walther H ^b   Mol, Jan A ^c   Rijnberk, Ad ^a   Kooistra, Hans S ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NONE

Author keywords

Feline; Hyperaldosteronism; Reference ranges; Renin angiotensin aldosterone system; Stress

Indexed keywords

ALDOSTERONE; ALPHA INTERMEDIN; CORTICOTROPIN; CREATININE; HYDROCORTISONE; RENIN; UREA;

ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; BREED; BREED DIFFERENCE; CAT; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOTROPIN BLOOD LEVEL; FEMALE; HEMOCONCENTRATION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN VERSUS ANIMAL COMPARISON; HYDROCORTISONE BLOOD LEVEL; HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; PLASMA RENIN ACTIVITY; REFERENCE VALUE; STANDARDIZATION; STRESS; SUPINE POSITION;

ADRENOCORTICOTROPIC HORMONE; ALDOSTERONE; ALPHA-MSH; ANIMALS; CATS; CREATINE KINASE; ELECTROLYTES; FEMALE; HEALTH; HYDROCORTISONE; MALE; RADIOIMMUNOASSAY; RENIN;

ANIMALIA; FELIDAE; FELIS CATUS; FELIS SILVESTRIS;

EID: 6444241611     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2004)18<625:PRAAPC>2.0.CO;2     Document Type: Article

References (51)

1. Littman M. Spontaneous systemic hypertension in 24 cats. J Vet Intern Med 1994;8:79-86.
2. Maggio F, Defrancesco TC, Atkins CE, et al. Ocular lesions associated with systemic hypertension in cats: 69 cases (1985-1998). J Am Vet Med Assoc 2000;217:695-702.
3. Chrispin SM, Mould JRB. Systemic hypertensive disease and the feline fundus. Vet Ophthalmol 2001;4:131-140.
4. Jensen J, Henik RA, Brownfield M, Armstrong J. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease. Am J Vet Res 1997;58:535-540.
5. Mishina M, Watanabe T, Fuji K, et al. Non-invasive blood pressure measurements in cats: Clinical significance of hypertension associated with chronic renal failure. J Vet Med 1998;60:805-808.
6. Bodey AR, Sansom J. Epidemiological study of blood pressure in domestic cats. J Small Anim Pract 1998;39:567-573.
7. Nelson OL, Reidesel E, Ware WA, Christensen WF. Echocardiographic and radiographic changes associated with systemic hypertension in cats. J Vet Intern Med 2002;16:418-425.
8. Corry DB, Tuck ML. Endocrine aspects of hypertension. In: Becker KL, ed. Principles and Practice of Endocrinology and Metabolism, 3rd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2001: 791-806.
9. Flood SM, Randolph JF, Gelzer ARM, Refsal K. Primary hyperaldosteronism in two cats. J Am Anim Hosp Assoc 1999;35:411-416.
10. Mackay AD, Holt PE, Sparkes AH. Successful surgical treatment of a cat with primary aldosteronism. J Feline Med Surg 1999;1: 117-122.
11. Moore LE, Biller DS, Smith TA. Use of abdominal ultrasonography in the diagnosis of primary hyperaldosteronism in a cat. J Am Vet Med Assoc 2000;217:213-215.
12. Rijnberk A, Voorhout G, Kooistra HS, et al. Hyperaldosteronism in a cat with metastasised adrenocortical tumour. Vet Q 2001;23: 38-43.
13. Steele JL, Henik RA, Stepien RL. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease. Vet Therap 2002;3:157-166.
14. Pedersen KM, Pedersen HD, Häggström J, et al. Increased mean arterial pressure and aldosterone-to-renin ratio in Persian cats with polycystic kidney disease. J Vet Intern Med 2003;17:21-27.
15. Dow SW, LeCouteur RA, Fettman MJ, Spurgeon TL. Potassium depletion in cats: Hypokalemic polymyopathy. J Am Vet Med Assoc 1987;191:1563-1568.
16. Dow SW, Fettman MJ, Curtis CR, LeCouteur RA. Hypokalemia in cats: 186 cases (1984-1987). J Am Vet Med Assoc 1989;194:1604-1608.
17. Syme HM, Barber PJ, Markwell PJ, Elliott J. Prevalence of systolic hypertension in cats with chronic renal failure at initial evaluation. J Am Vet Med Assoc 2002;220:1799-1804.
18. Hiramatsu K, Yamada Y, Ykimura Y, et al. A screening test to identify aldosterone-producing adenoma by measuring plasma rennin activity. Results in hypertensive patients. Arch Intern Med 1981;141: 1589-1593.
19. Gordon RD. Primary aldosteronism. J Endocrinol Invest 1995; 18:495-511.
20. Willemse T, Vroom MW, Mol JA, Rijnberk A. Changes in plasma cortisol, corticotropin, and α-melanocyte-stimulating hormone concentrations in cats before and after physical restraint and interadermal testing. Am J Vet Res 1993;54:69-72.
21. Kemppainen RJ, Peterson ME. Regulation of alpha-melanocyte-stimulating hormone secretion from the pars intermedia in domestic cats. Am J Vet Res 1999;60:245-249.
22. Javadi S, Kooistra HS, Mol JA, et al. Plasma aldosterone concentration and plasma renin activity in healthy dogs and in dogs with hyperadrenocorticism. Vet Rec 2003;153:521-525.
23. Boer P, Hene RJ, Koomans HA, et al. Blood and extracellular fluid volume in patients with Bartter's syndrome. Arch Intern Med 1983;143:1902-1905.
24. Boer P, Sleumer JH, Spriensma M. Confirmation of the optimal pH for measuring plasma renin activity in plasma. Clin Chem 1985; 31:149-150.
25. Reed AH, Henry RJ, Mason WB. Influence of statistical method used on the resulting estimate of normal range. Clin Chem 1971;17: 275-284.
26. 51Cr-EDTA clearance and its relation to several endogenous parameters of glomerular filtration. Res Vet Sci 1981;30:152-157.
27. Finco DR. Kidney Function. In: Kaneko JJ, Harvey JW, Bruss ML, eds. Clinical Biochemistry of Domestic Animals, 5th ed. San Diego, CA: Academic Press; 1997:441-484.
28. Feldhahn JR, Rand JS, Kinnaird E. The effect of interday variation and a short-term stressor on insulin sensitivity in clinically normal cats. J Feline Med Surg 1999;1:233-240.
29. Rand JS, Kinnaird E, Baglioni A, et al. Acute stress hyperglycemia in cats is associated with struggling and increased concentrations of lactate and norepinephrine. J Vet Intern Med 2002;16:123-132.
30. Fascetti AJ, Mauldin GE, Mauldin NG. Correlation between serum creatine kinase activities and anorexia in cats. J Vet Intern Med 1997;11:9-13.
31. Gulbin JP, Gaffney PT. Identical twins are discordant for markers of eccentric exercise-induced muscle damage. Int J Sports Med 2002;23:471-476.
32. Kemppainen RJ, Peterson ME. Domestic cats show episodic variation in plasma concentrations of adrenocorticotropin, alpha-melanocyte-stimulating hormone (alpha-MSH), cortisol and thyroxine with circadian variation in plasma alpha-MSH concentrations. Eur J Endocrinol 1996;134:602-609.
33. Kooistra HS, Greven SH, Mol JA, Rijnberk A. Pulsatile secretion of α-melanocyte-stimulating hormone (α-MSH) by the pars intermedia of the pituitary gland and differential effects of dexamethasone and haloperidol on the secretion of α-MSH and adrenocorticotrophic hormone in dogs. J Endocrinol 1997;152:113-121.
34. Van Eekelen JA, Oitzl MS, De Kloet ER. Adrenocortical hyporesponsiveness and glucocorticoid feedback resistance in old male brown Norway rats. J Gerontol A Biol Sci Med Sci 1995;50:B83-B89.
35. Kemppainen RJ, Sartin JL. Differential regulation of peptide release by the canine pars distalis and pars intermedia. Front Horm Res 1987;17:18-27.
36. Tilders FJH, Berkenbosch F, Smelik PG. Control of secretion of peptides related to adrenocorticotropin, melanocyte-stimulating hormone and endorphin. Front Horm Res 1985;14:161-196.
37. Goya RG, Castro MG, Meites J. Differential effect of aging on serum levels of prolactin and alpha-melanotropin in rats. Proc Soc Exp Biol Med 1991;196:218-221.
38. Jacob G, Ertl AC, Shannon JR, et al. Effect of standing on neurohumoral responses and plasma volume in healthy subjects. J Appl Physiol 1998;84:914-921.
39. Yu S, Morris JG. Plasma aldosterone concentrations of cats. Vet J 1998;155:63-68.
40. Hegstad R, Brown RD, Jiang NS, et al. Ageing and aldosterone. Am J Med 1983;74:442-448.
41. Radke KJ. Age-related impairment of K(+)- and ACTH-stimulated aldosterone secretion by rat adrenal capsules. Am J Physiol 1993;264:E82-E89.
42. Baas SJ, Endert E, Fliers E, et al. Establishment of reference values for endocrine tests. III: Primary aldosteronism. Neth J Med 2003;61:37-43.
43. Ait-Chaoui A, Rakotondrazafy J, Brudieux R. Age-related changes in plasma corticosterone and aldosterone responses to exogenous ACTH in the rat. Horm Res 1995;43:181-187.
44. Takeda R, Morimoto S, Uchida K, et al. Effect of age on plasma aldosterone response to exogenous angiotensin II in normotensive subjects. Acta Endocrinol 1980;94:552-558.
45. Giordano R, Di Vito L, Lanfranco F, et al. Elderly subjects show severe impairment of dehydroepiandrosterone sulphate and reduced sensitivity of cortisol and aldosterone response to the stimulatory effect of ACTH(1-24). Clin Endocrinol 2001;55:425-432.
46. Montori VM, Young WF Jr. Use of plasma aldosterone concentration-to- plasma renin activity as a screening test for primary aldosteronism. A systematic review of the literature. Endocrinol Metab Clin North Am 2002;31:619-632.
47. Kuroski de Bold ML. Estrogen, natriuretic peptides and the renin-angiotensin system. Cardiovasc Res 1999;41:524-531.
48. Roesch DM, Tian Y, Zheng W, et al. Estradiol attenuates angiotensin-induced aldosterone secretion in ovariectomized rats. Endocrinology 2000;141:4629-4636.
49. Kang AK, Miller JA. Effects of gender on the renin-angiotensin system, blood pressure, and renal function. Curr Hypertens Rep 2002; 4:143-151.
50. Findlay ALR, Fitsimons JT, Kucharczyk J. Dependence of spontaneous and angiotensin-induced drinking upon the estrous cycle and ovarian hormones. J Endocrinol 1979;82:215-225.
51. Kasiske BL. Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int 1987;31:1153-1159.